Literature DB >> 20687166

Open organ preservation surgery of the larynx: Experience of Istituto Nazionale Tumori of Milan.

Marco Guzzo1, Letizia Ferraro, Silvia Rezzonico, Tullio Ibba, Roberto Bianchi, Walter Fontanella, Gabriele Scaramellini.   

Abstract

BACKGROUND: The purpose of the present study was to report the oncological and functional results of our experience in open organ preservation surgery of the larynx.
METHODS: Between 1978 and 2006, 140 patients were treated with organ preservation surgery of the larynx. Feeding tube and tracheotomy duration, surgical infection, fistulae, and pneumonia were recorded.
RESULTS: Most patients were treated with supraglottic laryngectomies. Thirteen patients (9%) experienced a faringo-cutaneous fistula, 23 (16%) presented with a surgical site infection, and 6 (4%) developed pneumonia. Tracheotomy was maintained for a median period of 47 days in patients who did not receive postoperative radiotherapy (RT) and 140 days in patients who did. Eight (6%) total laryngectomies were performed because of oncological and functional reasons. Tube feeding continued for an average period of 34 days. Patients with squamous cell carcinoma (SCC) had 5-year disease-free survival (DFS) of 83.6%.
CONCLUSION: Open organ preservation surgery proved oncologically effective with good functional outcome and acceptable complications.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20687166     DOI: 10.1002/hed.21519

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Transoral CO₂ laser surgery for supraglottic cancer.

Authors:  Rocío González-Márquez; Juan P Rodrigo; Jose Luis Llorente; Cesar Alvarez-Marcos; Juan P Díaz; Carlos Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-07       Impact factor: 2.503

2.  Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes.

Authors:  Daniela Alterio; Simona Marani; Valeria Zurlo; Stefano Filippo Zorzi; Annamaria Ferrari; Stefania Volpe; Francesco Bandi; Sabrina Vigorito; Maria Giulia Vincini; Sara Gandini; Aurora Gaeta; Cristiana Iuliana Fodor; Alessia Casbarra; Mattia Zaffaroni; Anna Starzyńska; Liliana Belgioia; Mohssen Ansarin; Cynthia Aristei; Barbara Alicja Jereczek-Fossa
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.